HMGB1P19: A Drug Target / Disease Biomarker (G100419979)

Target Name: HMGB1P19

NCBI ID: G100419979

HMGB1P19

Other Name(s): High mobility group box 1 pseudogene 19 | high mobility group box 1 pseudogene 19

HMGB1P19: A Drug Target / Disease Biomarker

HMGB1P19 is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell proliferation and has been linked to a number of diseases, including cancer. As a result, it has generated a lot of interest as a potential drug target or biomarker.

HMGB1P19 is a transmembrane protein that is involved in a number of different signaling pathways. It is a negative regulator of the TGF-β pathway, which is a well-known signaling pathway that is involved in cell proliferation and differentiation. The TGF-β pathway is important for many different processes in the body, including cell growth, differentiation, and survival.

One of the things that makes HMGB1P19 an interesting target for drugs is its ability to regulate cell proliferation in a highly specific and efficient manner. It has been shown to play a key role in the regulation of cell proliferation in a variety of tissues, including cancer.

In addition to its role in cell proliferation, HMGB1P19 has also been linked to a number of diseases. For example, it has been shown to be involved in the development and progression of a variety of cancers, including breast, ovarian, and prostate cancers. It has also been linked to a number of other diseases, including heart disease, neurodegenerative diseases, and autoimmune disorders.

As a result of its involvement in so many different signaling pathways, HMGB1P19 has generated a lot of interest as a potential drug target. Researchers are actively working to develop compounds that can specifically target HMGB1P19 and modulate its activity. This is an important area of research because, if successful, these compounds could be used to treat a wide range of diseases.

Another promising aspect of HMGB1P19 is its ability to serve as a biomarker. Its expression has been shown to be associated with a number of different diseases, including cancer. This makes it an important candidate for use as a biomarker for a variety of diseases.

In addition to its potential as a drug target or biomarker, HMGB1P19 is also of interest to researchers because of its unique structure and biology. It is a transmembrane protein that is characterized by a number of unique features, including the presence of a hypervariable region (HVR) and a pro-domain. These features make it an interesting study object and have led to a number of studies aimed at understanding its biology and mechanism of action.

Overall, HMGB1P19 is a protein that has generated a lot of interest as a potential drug target or biomarker. Its ability to regulate cell proliferation in a specific and efficient manner, as well as its involvement in a number of diseases, makes it an important study object. Further research is needed to fully understand its biology and potential as a drug and biomarker.

Protein Name: High Mobility Group Box 1 Pseudogene 19

The "HMGB1P19 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HMGB1P19 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets